Array analysis of epilepsy-associated gangliogliomas reveals expression patterns related to aberrant development of neuronal precursors

Brain

Volumn 131, Issue 11, 2008, Pages 3034-3050

  Fassunke, Jana ^a   Majores, Michael ^a   Tresch, Achim ^b   Niehusmann, Pitt ^a   Grote, Alexander ^a   Schoch, Susanne ^a   Becker, Albert J ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Development; Dysplastic; Epilepsy; Glioneuronal; Migration; Network

Indexed keywords

PROTEIN KINASE C; PROTEIN LDB2; PROTEIN NELL2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO DEVELOPMENT; EPILEPSY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE SILENCING; GLIA; GLIOMA; HUMAN; HUMAN TISSUE; HYBRIDIZATION; IN SITU HYBRIDIZATION; MICRODISSECTION; MOUSE; NERVE CELL NETWORK; NEURAL STEM CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

BIOPSY; BRAIN NEOPLASMS; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN; EPILEPSIES, PARTIAL; GANGLIOGLIOMA; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

EID: 55749093729     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn233     Document Type: Article

References (88)

1. Abate LE, Mukherjee P, Seyfried TN. Gene-linked shift in ganglioside distribution influences growth and vascularity in a mouse astrocytoma. J Neurochem 2006; 98: 1973-84.
2. Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, et al. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Cancer Res 2005; 65: 4587-97.
3. Aronica E, Boer K, Becker A, Redeker S, Spliet WG, van Rijen PC, et al. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 2008; 151: 272-92.
4. Aronica E, Gorter JA, Redeker S, Ramkema M, Spliet WG, van Rijen PC, et al. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol Appl Neurobiol 2005; 31: 280-91.
5. Aronica E, Leenstra S, Jansen GH, van Veelen CW, Yankaya B, Troost D. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumours from patients with intractable epilepsy: colocalization with N-methyl-D-aspartic acid receptor. Acta Neuropathol 2001; 101: 383-92.
6. Aronica E, Ozbas-Gerceker F, Redeker S, Ramkema M, Spliet WG, van Rijen PC, et al. Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development. Acta Neuropathol 2004; 108: 422-34.
7. Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D, et al. CHD5 is a tumour suppressor at human 1p36. Cell 2007; 128: 459-75.
8. Ballman KV, Grill DE, Oberg AL, Therneau TM. Faster cyclic loess: normalizing RNA arrays via linear models. Bioinformatics 2004; 20: 2778-86.
9. Banker G, Goslin K. Culturing nerve cells. Vol. 2. Cambridge, MA: MIT Press; 1998.
10. Baron M, Kudin AP, Kunz WS. Mitochondrial dysfunction in neurodegenerative disorders. Biochem Soc Trans 2007; 35: 1228-31.
11. Becker AJ, Blümcke I, Urbach H, Hans V, Majores M. Molecular neuropathology of epilepsy-associated glioneuronal malformations. J Neuropathol Exp Neurol 2006; 65: 99-108.
12. Becker AJ, Chen J, Zien A, Sochivko D, Normann S, Schramm J, et al. Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur J Neurosci 2003; 18: 2792-802.
13. Becker AJ, Figarella-Branger D, Wiestler OD, Blümcke I. Ganglioglioma and gangliocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: IARC; 2007. p. 103-5.
14. Bentivoglio M, Tassi L, Pech E, Costa C, Fabene PF, Spreafico R. Cortical development and focal cortical dysplasia. Epileptic Disord 2003; 5 (Suppl 2): 27-34.
15. Benveniste RJ, Thor S, Thomas JB, Taghert PH. Cell type-specific regulation of the Drosophila FMRF-NH2 neuropeptide gene by Apterous, a LIM homeodomain transcription factor. Development 1998; 125: 4757-65.
16. Binder DK, Steinhauser C. Functional changes in astroglial cells in epilepsy. Glia 2006; 54: 358-68.
17. Blümcke I, Giencke K, Wardelmann E, Beyenburg S, Kral T, Sarioglu N, et al. The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol 1999; 97: 481-90.
18. Blümcke I, Thom M, Wiestler OD. Ammon's horn sclerosis: a maldevelopmental disorder associated with temporal lobe epilepsy. Brain Pathol 2002; 12: 199-211.
19. Brehelin L, Gascuel O, Martin O. Using repeated measurements to validate hierarchical gene clusters. Bioinformatics 2008; 24: 682-88.
20. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-3.
21. Cepeda C, Andre VM, Wu N, Yamazaki I, Uzgil B, Vinters HV, et al. Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia. Epilepsia 2007; 48 (Suppl 5): 79-85.
22. Chen J, Sochivko D, Beck H, Marechal D, Wiestler OD, Becker AJ. Activity-induced expression of common reference genes in individual cns neurons. Lab Invest 2001; 81: 913-16.
23. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 2005; 437: 1365-69.
24. Crino PB, Becker AJ. Gene profiling in temporal lobe epilepsy tissue and dysplastic lesions. Epilepsia 2006; 47: 1608-16.
25. Daumas-Duport C, Pietsch T, Hawkins C, Shankar SK. Dysembryoplastic neuroepithelial tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system. Lyon: IARC; 2007. p. 99-102.
26. Dawid IB, Breen JJ, Toyama R. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet 1998; 14: 156-62.
27. Dudoit S, Yang YH, Callow MJ, Speed TP. Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Stat Sin 2002; 12: 111-39.
28. Elger CE. Epilepsy: disease and model to study human brain function. Brain Pathol 2002; 12: 193-98.
29. Fassunke J, Majores M, Ullmann C, Elger CE, Schramm J, Wiestler OD, et al. In situ-RT and immunolaser microdissection for mRNA analysis of individual cells isolated from epilepsy-associated glioneuronal tumours. Lab Invest 2004; 84: 1520-25.
30. Fernandez-Funez P, Lu CH, Rincon-Limas DE, Garcia-Bellido A, Botas J. The relative expression amounts of apterous and its co-factor dLdb/Chip are critical for dorso-ventral compartmentalization in the Drosophila wing. Embo J 1998; 17: 6846-53.
31. Fillmore HL, VanMeter TE, Broaddus WC. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neurooncol 2001; 53: 187-202.
32. Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4: 1329-33.
33. Golden JA. Cell migration and cerebral cortical development. Neuropathol Appl Neurobiol 2001; 27: 22-8.
34. Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, et al. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 2006; 26: 11083-110.
35. Harduin-Lepers A, Stokes DC, Steelant WF, Samyn-Petit B, Krzewinski-Recchi MA, Vallejo-Ruiz V, et al. Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV. Biochem J 2000; 352: 37-48.
36. Heinemann U. Basic mechanisms of partial epilepsies. Curr Opin Neurol 2004; 17: 155-9.
37. Hoischen A, Ehrler M, Fassunke J, Simon M, Baudis M, Landwehr C, et al. Comprehensive characterization of genomic aberrations in gangliogliomas by comparative genomic hybridization (CGH), array-based CGH and interphase-FISH. Brain Pathol 2008; 18: 326-37.
38. Hurd EA, Capers PL, Blauwkamp MN, Adams ME, Raphael Y, Poucher HK, et al. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome 2007; 18: 94-104.
39. Kanazawa M, Terada K, Kato S, Mori M. HSDJ, a human homolog of DnaJ, is farnesylated and is involved in protein import into mitochondria. J Biochem 1997; 121: 890-5.
40. Kang HJ, Adams DH, Simen A, Simen BB, Rajkowska G, Stockmeier CA, et al. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. J Neurosci 2007; 27: 13329-40.
41. Kim SK, Wang KC, Hong SJ, Chung CK, Lim SY, Kim YY, et al. Gene expression profile analyses of cortical dysplasia by cDNA arrays. Epilepsy Res 2003; 56: 175-83.
42. Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, Caunt JC, et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 2004; 279: 42703-8.
43. Knafo S, Grossman Y, Barkai E, Benshalom G. Olfactory learning is associated with increased spine density along apical dendrites of pyramidal neurons in the rat piriform cortex. Eur J Neurosci 2001; 13: 633-8.
44. Kral T, Clusmann H, Blümcke I, Fimmers R, Ostertun B, Kurthen M, et al. Outcome of epilepsy surgery in focal cortical dysplasia. J Neurol Neurosurg Psychiatry 2003; 74: 183-8.
45. Kral T, Clusmann H, Urbach J, Schramm J, Elger CE, Kurthen M, et al. Preoperative evaluation for epilepsy surgery (Bonn Algorithm). Zentralbl Neurochir 2002; 63: 106-10.
46. Kuo TY, Hsueh YP. Expression of zinc finger transcription factor Bcl11A/Evi9/CTIP1 in rat brain. J Neurosci Res 2007; 85: 1628-36.
47. Landau BJ, Kwaan HC, Verrusio EN, Brem SS. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumours. Cancer Res 1994; 54: 1105-8.
48. Lukasiuk K, Kontula L, Pitkanen A. cDNA profiling of epileptogenesis in the rat brain. Eur J Neurosci 2003; 17: 271-9.
49. Lundgren SE, Callahan CA, Thor S, Thomas JB. Control of neuronal pathway selection by the Drosophila LIM homeodomain gene apterous. Development 1995; 121: 1769-73.
50. Luyken C, Blümcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, et al. The spectrum of long-term epilepsy-associated tumours: long-term seizure and tumour outcome and neurosurgical aspects. Epilepsia 2003; 44: 822-30.
51. McNamara RK, Wees EA, Lenox RH. Differential subcellular redistribution of protein kinase C isozymes in the rat hippocampus induced by kainic acid. J Neurochem 1999; 72: 1735-43.
52. Milatovic D, Zaja-Milatovic S, Montine KS, Shie FS, Montine TJ. Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo. J Neuroinflammation 2004; 1: 20.
53. Miller DJ, Wang Y, Kesidis G. Emergent unsupervised clustering paradigms with potential application to bioinformatics. Front Biosci 2008; 13: 677-90.
54. Nelson BR, Claes K, Todd V, Chaverra M, Lefcort F. NELL2 promotes motor and sensory neuron differentiation and stimulates mitogenesis in DRG in vivo. Dev Biol 2004; 270: 322-35.
55. Nicholls CD, Shields MA, Lee PW, Robbins SM, Beattie TL. UV-dependent alternative splicing uncouples p53 activity and PIG3 gene function through rapid proteolytic degradation. J Biol Chem 2004; 279: 24171-8.
56. Niino YS, Ohno S, Suzuki K. Positive and negative regulation of the transcription of the human protein kinase C beta gene. J Biol Chem 1992; 267: 6158-63.
57. Oh S, Iwahori A, Kato S. Human cDNA encoding DnaJ protein homologue. Biochim Biophys Acta 1993; 1174: 114-6.
58. Ostendorff HP, Tursun B, Cornils K, Schluter A, Drung A, Gungor C, et al. Dynamic expression of LIM cofactors in the developing mouse neural tube. Dev Dyn 2006; 235: 786-91.
59. Pace A, Bove L, Innocenti P, Pietrangeli A, Carapella CM, Oppido P, et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J Exp Clin Cancer Res 1998; 17: 479-82.
60. Parruti G, Peracchia F, Sallese M, Ambrosini G, Masini M, Rotilio D, et al. Molecular analysis of human beta-arrestin-1: cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing. J Biol Chem 1993; 268: 9753-61.
61. Pfaff SL, Mendelsohn M, Stewart CL, Edlund T, Jessell TM. Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 1996; 84: 309-20.
62. Prayson RA. Bcl-2 and Bcl-X expression in gangliogliomas. Hum Pathol 1999; 30: 701-5.
63. Raychaudhuri S, Sutphin PD, Chang JT, Altman RB. Basic microarray analysis: grouping and feature reduction. Trends Biotechnol 2001; 19: 189-93.
64. Rocke DM, Durbin B. A model for measurement error for gene expression arrays. J Comput Biol 2001; 8: 557-69.
65. Rorive S, Maris C, Debeir O, Sandras F, Vidaud M, Bieche I, et al. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. J Neuropathol Exp Neurol 2006; 65: 794-807.
66. Samadani U, Judkins AR, Akpalu A, Aronica E, Crino PB. Differential cellular gene expression in ganglioglioma. Epilepsia 2007; 48: 646-53.
67. Schick V, Majores M, Engels G, Spitoni S, Koch A, Elger CE, et al. Activation of Akt independent of PTEN and CTMP tumour-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias. Acta Neuropathol 2006; 112: 715-25.
68. Schick V, Majores M, Fassunke J, Engels G, Simon M, Elger CE, et al. Mutational and expression analysis of CDK1, cyclinA2 and cyclinB1 in epilepsy-associated glioneuronal lesions. Neuropathol Appl Neurobiol 2007a; 33: 152-62.
69. Schick V, Majores M, Koch A, Elger CE, Schramm J, Urbach H, et al. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions. Epilepsia 2007b; 48 (Suppl 5): 65-73.
70. Schwartzkroin PA, Walsh CA. Cortical malformations and epilepsy. Ment Retard Dev Disabil Res Rev 2000; 6: 268-80.
71. Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007; 67: 890-900.
72. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007; 39: 226-31.
73. Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, et al. Human postmortem tissue: what quality markers matter? Brain Res 2006; 1123: 1-11.
74. Takeya R, Takeshige K, Sumimoto H. Interaction of the PDZ domain of human PICK1 with class I ADP-ribosylation factors. Biochem Biophys Res Commun 2000; 267: 149-55.
75. Tang Y, Lu A, Aronow BJ, Wagner KR, Sharp FR. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 2002; 15: 1937-52.
76. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 2004; 25: 77-107.
77. Thom M, Martinian L, Sen A, Cross JH, Harding BN, Sisodiya SM. Cortical neuronal densities and lamination in focal cortical dysplasia. Acta Neuropathol 2005; 110: 383-92.
78. Tsai SC, Haun RS, Tsuchiya M, Moss J, Vaughan M. Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin. J Biol Chem 1991; 266: 23053-59.
79. Watanabe TK, Katagiri T, Suzuki M, Shimizu F, Fujiwara T, Kanemoto N, et al. Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics 1996; 38: 273-6.
80. Way JC, Chalfie M. mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans. Cell 1988; 54: 5-16.
81. Williams DW, Truman JW. Mechanisms of dendritic elaboration of sensory neurons in Drosophila: insights from in vivo time lapse. J Neurosci 2004; 24: 1541-50.
82. Wolf HK, Birkholz T, Wellmer J, Blümcke I, Pietsch T, Wiestler OD. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies. J Neuropathol Exp Neurol 1995a; 54: 689-97.
83. Wolf HK, Roos D, Blümcke I, Pietsch T, Wiestler OD. Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol 1996; 91: 376-84.
84. Wolf HK, Wellmer J, Muller MB, Wiestler OD, Hufnagel A, Pietsch T. Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumours in patients with chronic pharmacoresistant epilepsies. J Neuropathol Exp Neurol 1995b; 54: 245-54.
85. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008; 49: 8-21.
86. Wu GY, Zou DJ, Rajan I, Cline H. Dendritic dynamics in vivo change during neuronal maturation. J Neurosci 1999; 19: 4472-83.
87. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: e15.
88. Yu RK, Holley JA, Macala LJ, Spencer DD. Ganglioside changes associated with temporal lobe epilepsy in the human hippocampus. Yale J Biol Med 1987; 60: 107-17.